Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cholesterol may play role in cognitive decline

Publish date:: May 6, 2020

Key clinical point: Adults with total cholesterol in the low/normal range may have reduced semantic fluency and lower gray matter volume compared with other individuals.

Major finding: Lower cholesterol was associated with reduced semantic fluency, but no relationship was observed between cognitive performance and total cholesterol in individuals with high cholesterol; groups with total cholesterol below 160 mg/dL also had significantly lower gray matter volume than other groups (P < 0.05).

Study details: The data come from 117 non-demented adults, including 67 with Parkinson’s disease and 50 matched controls.

Disclosures: The study was supported by PPMI, a public–private partnership funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners including AbbVie, Avid Radiopharmaceuticals, Biogen Idec, Bristol–Myers Squibb, Covance, Eli Lilly, F. Hoffman–La Roche, GE Healthcare, Genentech, GlaxoSmithKline, Lundbeck, Merck, MesoScale, Piramal, Pfizer, Prevail, and UCB.

Citation:

Yang FN et al. Front Aging Neurosci. 2020 Mar 31. doi: 10.3389/fnagi.202000057.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Dementia

Hemoglobin, age, RNA may predict mild dementia in kidney disease patients,

Reduced physical activity hinders dementia prevention efforts,

Baseline dementia predicts poor oral health,

Sauna time may mitigate dementia risk,

Rural residents with dementia have shorter survival than urban dwellers,